Welcome to CKB CORE's new home! Please be sure to update any bookmarks you may have.
×

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01887717
Title Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein
Acronym YES-P
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors BTG International Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | GBR | FRA | ESP | BEL


No variant requirements are available.